Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-06-12 Purchase |
2023-06-14 4:00 pm |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
28,000 | $0.35086 | $9,824 | 94,726 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-02-21 Option Award |
2023-02-23 8:00 pm |
N/A 2033-02-21 |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
210,000 | $0 | 210,000 (Direct) |
View |
2023-01-03 Tax Withholding |
2023-01-05 6:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
6,266 | $1.02 | 66,726 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 6:21 pm |
N/A 2032-07-28 |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
71,875 | $0 | 101,742 (Direct) |
View |
2022-01-20 Option Award |
2022-01-24 4:00 pm |
N/A 2032-01-20 |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
162,457 | $0 | 162,457 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 7:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
29,867 | $0 | 29,867 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 6:00 pm |
N/A 2031-02-11 |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
253,000 | $0 | 253,000 (Direct) |
View |